Human MHCE/HLA-E (Major Histocompatibility Complex Class I E) ELISA Kit (HUES03207)
- SKU:
- HUES03207
- Product Type:
- ELISA Kit
- Size:
- 96 Assays
- Uniprot:
- Q6DU44
- Sensitivity:
- 0.19ng/mL
- Range:
- 0.31-20ng/mL
- ELISA Type:
- Sandwich
- Synonyms:
- MHC-E, HLAE, EA1.2, EA2.1, HLA-6.2, QA1
- Reactivity:
- Human
- Sample Type:
- Serum, plasma and other biological fluids
- Research Area:
- Immunology
Description
Human MHCE/HLA-E (Major Histocompatibility Complex Class I E) ELISA Kit
The Human MHC E (HLA-E) ELISA Kit is specifically designed for the precise measurement of major histocompatibility complex class I E levels in human serum, plasma, and cell culture supernatants. With its exceptional sensitivity and specificity, this kit delivers consistently accurate and reproducible results, making it an indispensable tool for a wide array of research applications.Major histocompatibility complex class I E, also known as HLA-E, plays a critical role in the immune response by presenting antigens to killer T cells.
Dysregulation of HLA-E expression has been linked to various autoimmune diseases, infectious diseases, and cancers, highlighting its importance as a biomarker in understanding and developing treatments for these conditions.Overall, the Human MHC E (HLA-E) ELISA Kit offers researchers a reliable and efficient method for studying major histocompatibility complex class I E levels in human samples, ultimately contributing to advancements in the field of immunology and beyond.
| Assay type: | Sandwich |
| Format: | 96T |
| Assay time: | 4.5h |
| Reactivity: | Human |
| Detection Method: | Colormetric |
| Detection Range: | 0.31-20 ng/mL |
| Sensitivity: | 0.19 ng/mL |
| Sample Volume Required Per Well: | 100µL |
| Sample Type: | Serum, plasma and other biological fluids |
| Specificity: | This kit recognizes Human MHCE/HLA-E in samples. No significant cross-reactivity or interference between Human MHCE/HLA-E and analogues was observed. |
This ELISA kit uses Sandwich-ELISA as the method. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human MHCE/HLA-E. Standards or samples are added to the appropriate micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human MHCE/HLA-E and Avidin-Horseradish Peroxidase (HRP) conjugate are added to each micro plate well successively and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human MHCE/HLA-E, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by adding Stop Solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human MHCE/HLA-E. The concentration of Human MHCE/HLA-E in samples can be calculated by comparing the OD of the samples to the standard curve.
| UniProt Protein Function: | Non-classical major histocompatibility class Ib molecule involved in immune self-nonself discrimination. In complex with B2M/beta-2-microglobulin binds nonamer self-peptides derived from the signal sequence of classical MHC class Ia molecules (VL9 peptides) (PubMed:9754572, PubMed:18083576, PubMed:18339401). Peptide-bound HLA-E-B2M heterotrimeric complex primarily functions as a ligand for natural killer (NK) cell inhibitory receptor KLRD1-KLRC1, enabling NK cells to monitor the expression of other MHC class I molecules in healthy cells and to tolerate self (PubMed:9754572, PubMed:9486650, PubMed:17179229, PubMed:18083576). Upon cellular stress, preferentially binds signal sequence-derived peptides from stress-induced chaperones and is no longer recognized by NK cell inhibitory receptor KLRD1-KLRC1, resulting in impaired protection from NK cells (PubMed:12461076). Binds signal sequence-derived peptides from non-classical MHC class Ib HLA-G molecules and acts as a ligand for NK cell activating receptor KLRD1-KLRC2, likely playing a role in the generation and effector functions of adaptive NK cells and in maternal-fetal tolerance during pregnancy (PubMed:9754572, PubMed:30134159). Besides self-peptides, can also bind and present pathogen-derived peptides conformationally similar to VL9 peptides to alpha-beta T cell receptor (TCR) on unconventional CD8+ cytotoxic T cells, ultimately triggering antimicrobial immune response (PubMed:16474394, PubMed:30087334). |
| NCBI Summary: | HLA-E belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. HLA-E binds a restricted subset of peptides derived from the leader peptides of other class I molecules. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 encode the cytoplasmic tail. [provided by RefSeq, Jul 2008] |
| UniProt Code: | Q6DU44 |
| NCBI GenInfo Identifier: | 62912479 |
| NCBI Gene ID: | 3133 |
| NCBI Accession: | NP_005507. 3 |
| UniProt Secondary Accession: | Q6DU44,Q30169, Q6DU44, Q9BT83, Q9GIY7, Q9GIY8, E2G051 |
| UniProt Related Accession: | P13747 |
| Molecular Weight: | 40,058 Da |
| NCBI Full Name: | HLA class I histocompatibility antigen, alpha chain E |
| NCBI Synonym Full Names: | major histocompatibility complex, class I, E |
| NCBI Official Symbol: | HLA-E |
| NCBI Official Synonym Symbols: | QA1; HLA-6. 2 |
| NCBI Protein Information: | HLA class I histocompatibility antigen, alpha chain E |
| UniProt Protein Name: | HLA class I histocompatibility antigen, alpha chain E |
| UniProt Synonym Protein Names: | MHC class I antigen E |
| UniProt Gene Name: | HLA-E |
As the OD values of the standard curve may vary according to the conditions of the actual assay performance (e. g. operator, pipetting technique, washing technique or temperature effects), the operator should establish a standard curve for each test. Typical standard curve and data is provided below for reference only.
| Concentration (ng/mL) | O.D | Average | Corrected |
| 20 | 2.33 2.334 | 2.332 | 2.257 |
| 10 | 1.502 1.534 | 1.518 | 1.443 |
| 5 | 0.82 0.792 | 0.806 | 0.731 |
| 2.5 | 0.404 0.416 | 0.41 | 0.335 |
| 1.25 | 0.272 0.244 | 0.258 | 0.183 |
| 0.63 | 0.177 0.153 | 0.165 | 0.09 |
| 0.31 | 0.119 0.123 | 0.121 | 0.046 |
| 0 | 0.072 0.078 | 0.075 | -- |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, mid range and high level Human MHCE/HLA-E were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, mid range and high level Human MHCE/HLA-E were tested on 3 different plates, 20 replicates in each plate.
| Intra-assay Precision | Inter-assay Precision | |||||
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 1.07 | 2.66 | 9.08 | 0.99 | 2.73 | 8.59 |
| Standard deviation | 0.05 | 0.13 | 0.31 | 0.06 | 0.13 | 0.46 |
| C V (%) | 4.67 | 4.89 | 3.41 | 6.06 | 4.76 | 5.36 |
Recovery
The recovery of Human MHCE/HLA-E spiked at three different levels in samples throughout the range of the assay was evaluated in various matrices.
| Sample Type | Range (%) | Average Recovery (%) |
| Serum (n=5) | 90-104 | 95 |
| EDTA plasma (n=5) | 89-102 | 94 |
| Cell culture media (n=5) | 93-107 | 100 |
Linearity
Samples were spiked with high concentrations of Human MHCE/HLA-E and diluted with Reference Standard & Sample Diluent to produce samples with values within the range of the assay.
| Serum (n=5) | EDTA plasma (n=5) | Cell culture media (n=5) | ||
| 1:2 | Range (%) | 98-114 | 96-113 | 98-111 |
| Average (%) | 105 | 104 | 104 | |
| 1:4 | Range (%) | 88-104 | 85-96 | 87-102 |
| Average (%) | 95 | 90 | 93 | |
| 1:8 | Range (%) | 93-105 | 86-96 | 84-95 |
| Average (%) | 100 | 91 | 89 | |
| 1:16 | Range (%) | 91-106 | 83-96 | 84-98 |
| Average (%) | 98 | 88 | 91 |
An unopened kit can be stored at 4°C for 1 month. If the kit is not used within 1 month, store the items separately according to the following conditions once the kit is received.
| Item | Specifications | Storage |
| Micro ELISA Plate(Dismountable) | 8 wells ×12 strips | -20°C, 6 months |
| Reference Standard | 2 vials | |
| Concentrated Biotinylated Detection Ab (100×) | 1 vial, 120 µL | |
| Concentrated HRP Conjugate (100×) | 1 vial, 120 µL | -20°C(shading light), 6 months |
| Reference Standard & Sample Diluent | 1 vial, 20 mL | 4°C, 6 months |
| Biotinylated Detection Ab Diluent | 1 vial, 14 mL | |
| HRP Conjugate Diluent | 1 vial, 14 mL | |
| Concentrated Wash Buffer (25×) | 1 vial, 30 mL | |
| Substrate Reagent | 1 vial, 10 mL | 4°C(shading light) |
| Stop Solution | 1 vial, 10 mL | 4°C |
| Plate Sealer | 5 pieces | |
| Product Description | 1 copy | |
| Certificate of Analysis | 1 copy |
- Set standard, test sample and control (zero) wells on the pre-coated plate and record theirpositions. It is recommended to measure each standard and sample in duplicate. Note: addall solutions to the bottom of the plate wells while avoiding contact with the well walls. Ensuresolutions do not foam when adding to the wells.
- Aliquot 100µl of standard solutions into the standard wells.
- Add 100µl of Sample / Standard dilution buffer into the control (zero) well.
- Add 100µl of properly diluted sample (serum, plasma, tissue homogenates and otherbiological fluids) into test sample wells.
- Cover the plate with the sealer provided in the kit and incubate for 90 min at 37°C.
- Aspirate the liquid from each well, do not wash. Immediately add 100µL of BiotinylatedDetection Ab working solution to each well. Cover the plate with a plate seal and gently mix. Incubate for 1 hour at 37°C.
- Aspirate or decant the solution from the plate and add 350µL of wash buffer to each welland incubate for 1-2 minutes at room temperature. Aspirate the solution from each well andclap the plate on absorbent filter paper to dry. Repeat this process 3 times. Note: a microplatewasher can be used in this step and other wash steps.
- Add 100µL of HRP Conjugate working solution to each well. Cover with a plate seal andincubate for 30 min at 37°C.
- Aspirate or decant the solution from each well. Repeat the wash process for five times asconducted in step 7.
- Add 90µL of Substrate Reagent to each well. Cover with a new plate seal and incubate forapproximately 15 min at 37°C. Protect the plate from light. Note: the reaction time can beshortened or extended according to the actual color change, but not by more than 30min.
- Add 50 µL of Stop Solution to each well. Note: Adding the stop solution should be done inthe same order as the substrate solution.
- Determine the optical density (OD value) of each well immediately with a microplate readerset at 450 nm.
Related Products
Human HLA-C / Major Histocompatibility Complex Class I C ELISA Kit
Human HLA class I histocompatibility antigen, alpha chain E (HLA-E) ELISA Kit (HUEB1781)
Human Major Histocompatibility Complex Class I A (MHCA) ELISA Kit
Human Major Histocompatibility Complex Class I G (MHCG) ELISA Kit
Human Major Histocompatibility Complex Class I B (MHCB) ELISA Kit
